PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34165175-5	2021	The aim of the present study was to evaluate the combination of CAR T cells with the SINE compounds eltanexor and selinexor.	Eltanexor	100-109	nuclear receptor subfamily 1 group I member 3	Homo sapiens	64-67	
34165175-9	2021	Due to CAR T-cell toxicity, sequential use of SINEs and CAR T cells was evaluated: Cytotoxicity of CAR T cells increased significantly when target cells were pre-treated with the SINE compound eltanexor.	Eltanexor	193-202	nuclear receptor subfamily 1 group I member 3	Homo sapiens	56-59	
34165175-10	2021	In addition, exhaustion of CAR T cells decreased when target cells were pre-treated with eltanexor.	Eltanexor	89-98	nuclear receptor subfamily 1 group I member 3	Homo sapiens	27-30